Nothing Special   »   [go: up one dir, main page]

Perrone et al., 2017 - Google Patents

Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier

Perrone et al., 2017

View PDF
Document ID
3446039022789479053
Author
Perrone M
Vitale P
Ferorelli S
Boccarelli A
Coluccia M
Pannunzio A
Campanella F
Di Mauro G
Bonaccorso C
Fortuna C
Scilimati A
Publication year
Publication venue
European Journal of Medicinal Chemistry

External Links

Snippet

Neuroinflammation is the earliest stage of several neurological and neurodegenerative diseases. In the case of neurodegenerative disorders, it takes place about 15–20 years before the appearance of specific neurodegenerative clinical symptoms. Constitutive …
Continue reading at ricerca.uniba.it (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Similar Documents

Publication Publication Date Title
CN105102431B (en) The benzene compound being substituted
Perrone et al. Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier
Kim et al. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity
DK2568976T3 (en) Zanamivir-phosphonate congener with the anti-influenza activity, and determining the sensitivity oseltamivir in influenza viruses
Wu et al. In vitro and in vivo evaluation of the antidiabetic activity of ursolic acid derivatives
KR102626669B1 (en) Compounds and their uses for the prevention and treatment of diseases
US8217155B2 (en) Metabolites and derivatives of ambrisentan
CN101600730A (en) Send method, compound, composition and the carrier of 3-amino-1-propanesulfonic acid
CN108395443A (en) Inhibit the cyclic compound and application thereof of programmed death receptors ligand 1
Wu et al. Oleanolic acid indole derivatives as novel α-glucosidase inhibitors: Synthesis, biological evaluation, and mechanistic analysis
KR20220079866A (en) therapeutic conjugate
Ma et al. Synthesis, anti-fungal and 1, 3-β-d-glucan synthase inhibitory activities of caffeic and quinic acid derivatives
Lu et al. Design and synthesis of sulfonium derivatives: a novel class of α-glucosidase inhibitors with potent in vivo antihyperglycemic activities
Lu et al. Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy
CN107382796B (en) CA-4 antineoplastic medicine, synthetic method and application thereof
CN109096219A (en) A kind of novel anti-PD-L1 compound, its application and the composition containing it
US10745434B2 (en) Uridine phosphoramide prodrug, preparation method therefor, and medicinal uses thereof
Fu et al. Synthesis and evaluation of inhibitors of Mycobacterium tuberculosis UGM using bioisosteric replacement
Gao et al. Total synthesis of the proposed structure of Penasulfate A: L-Arabinose as a source of chirality
CN114507179B (en) Para-benzene ring butanamide rosemary compound serving as hyaluronidase inhibitor and application of para-benzene ring butanamide rosemary compound in beauty products
Tanabe et al. Highly Diastereoselective Route to α-Glucosidase Inhibitors, Neosalacinol and Neoponkoranol
EP3543228B1 (en) Compound having anticancer activity, and preparation method and application thereof
Mo et al. Vortioxetine Derivatives with Amino Acid as Promoiety: Synthesis, Activity, Stability and Preliminary Pharmacokinetic Study
CN114437046B (en) 5-fluorouracil spliced 4-aniline quinazoline compound and preparation method and application thereof
CN113171467B (en) Chimeric molecule based on NQO1 regulation and control and application thereof